Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This compound is supplied solely for laboratory and R&D purposes
Inhibition of lipid synthase activity: AOD 9604 reduces the activities of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC), and decreases de novo synthesis of fatty acids
Long-Lasting Hydration Hydrated skin appears healthier, brighter and more comfortable
Compounded micronutrient injections: Evidence-based dosing guidelines
Pre-existing inborn errors of sulfur-amino-acid metabolism (e.g., homocystinuria) represent an absolute contraindication because parenteral methionine can exacerbate elevated homocysteine concentrations and associated thrombotic risk
National Center for Advancing Translational Sciences GSRS record lists LAT-8881 and AOD-9604 as names associated with the same peptide substance identity
US$ 23.53
US$ 20.50
US$ 29.48
US$ 21.99
US$ 21.24
US$ 20.34
US$ 29.10
